Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

90 results about "Genistein" patented technology

Genistein is an isoflavone that is described as an angiogenesis inhibitor and a phytoestrogen. It was first isolated in 1899 from the dyer's broom, Genista tinctoria; hence, the chemical name. The compound structure was established in 1926, when it was found to be identical with that of prunetol. It was chemically synthesized in 1928.

Kudzuvine root fermentation product with blood pressure lowering effect and preparation method thereof

The invention belongs to the technical field of traditional Chinese medicine fermentation, and particularly relates to a radix puerariae fermented product with a blood pressure reducing effect and a preparation method thereof. The preparation method comprises the following steps: (1) adding water into kudzuvine root powder, uniformly mixing, and carrying out ultrasonic treatment to obtain a mixed solution; (2) sterilizing the mixed solution to obtain a sterilized solution; and (3) adding a leavening agent into the sterilized solution, fermenting at 25-35 DEG C for 24-72 hours to obtain a fermentation solution, and performing solid-liquid separation on the fermentation solution to obtain a fermentation supernatant, namely a fermentation product. According to the method, the content of puerarin, genistein and total triterpenes in the radix puerariae fermentation liquor can be increased, and a very good blood pressure reducing effect is achieved.
Owner:江苏菌钥生命科技发展有限公司

Genistein for asthma treatment

A novel method of treating diseases characterized by high PAI-1 is presented. Administering a composition comprising a therapeutically effective amount of genistein was found to inhibit PAI-1 promotor activity and decrease PAI-1 levels to treat diseases such as asthma, which exhibit increased PAI-1 levels. Genotyping the patient can be performed prior to administration to detect a 4G / 5G polymorphism as patients having a 4G genotype have better response to the genistein treatment. The composition may be comprised of a therapeutically effective amount of genistein derived naturally from soybeans or synthetically produced and optionally present in nanoparticle form.
Owner:ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO +1

Compositions for protecting cells from oxidative and mitochondrial stress

The present invention describes a composition comprising an effective amount of a combination of two or more components selected from acacetin, ACT1 peptide, α-lipoic acid, alprostadil, anisomycin, apigenin, ascorbic acid, astragalus, berberine, β-lapachone, β-hydroxy-β-methylbutyrate, bacopa monnieri, catechins, catechols, chamomile, chrysin, coumestrol, curcumin, dinitrophenol, dinoprost, ellagic acid, (-)-epigallocatechin gallate, green tea extract, fisetin, genistein, ginsenoside RE, glabridin, 18-α-glycyrrhetinic acid, 18-β-glycyrrhetinic acid, glycyrrhizin, hydroquinone, isoquercetin (EMIQ), shan Phosphate, black bean anthocyanins, leucine, lithium, luteolin, luteolin, luteolin, melatonin, menadione, 1‑methylnicotinamide (MNA), methyl salicylate, myricetin, nicotinamide adenine dinucleotide, nicotinic acid (vitamin B3), nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid adenine dinucleotide (NaAD), nicotinic acid mononucleotide (NaMN), parsley, phenylephrine, pokeweed mitogen, 15‑Δ prostaglandin J2, puromycin, quercetin, quinolinic acid, retinoic acid, trichostatin A, troxerutin, rutin, tryptophan, vitamin D3, withaferin A, wortmannin, and zinc (including its salts).
Owner:NUKIDU LTD

Skin moisturizing functional transfersome cosmetic composition and method of preparing the same

Provided is a transfersome cosmetic composition including: a Matricaria flower extract, a Centella asiatica extract, an Arnica montana flower extract, a Scutellaria baicalensis extract, a Paeonia suffruticosa root extract, an aloe vera leaf extract, a Saccharina japonica extract, a licorice root extract, a lactobacillus lysate formed by fermenting strains belonging the lactobacillus genus, a rice bran fermentation filtrate formed by fermenting rice bran using a first composite strain including strains belonging to the bacillus genus, strains belonging to the lactobacillus genus, and yeast, a green tea fermentation extract formed by fermenting green tea using a second composite strain including strains belonging to the Aspergillus genus and strains belonging to the Lactobacillus genus, a grape seed oil, an jojoba seed oil, hydroxyacetophenone, Bifidobacterium, arginine, betaine, trehalose, sodium hyaluronate, hydrolyzed elastin, Ceramide NP, resveratrol, Genistein, tocopheryl acetate, glycerin, and purified water.
Owner:RADKIN

10MG to 35MG of gildeuretinol for use in the treatment of stargardt disease

Disclosed is a method of treating a patient with Stargardt Disease. Also disclosed is a method of delaying the progression of vision loss in a patient with Stargardt Disease. The methods comprise administering to the patient from 10 mg to 35 mg per day of gildeuretinol acetate.
Owner:ALKEUS PHARMACEUTICALS INC

Method for increasing contents of genistin and genistein in flemingia philippinensis by using potassium

The invention discloses a method for increasing the content of genistin and genistein in flemingia philippinensis by using potassium. Culturing the flemingia philippinensis tissue culture seedlings in a propagation culture medium, and subculturing to obtain flemingia philippinensis stem segments with leaves; taking stems of the flemingia philippinensis, and culturing the stems in a rooting culture medium to obtain the flemingia philippinensis with the content of genistin and genistein increased; wherein the propagation culture medium is prepared from MS (Murashige and Skoog), 6-benzyladenine, indoleacetic acid and kinetin; the rooting culture medium comprises KNO3, MS (Murashige and Skoog) and naphthylacetic acid, and the MS does not contain KNO3. According to the method for increasing the content of genistin and genistein in the flemingia philippinensis by using potassium, accumulation of active ingredients of genistin and genistein at the root of the flemingia philippinensis is adjusted by adding exogenous potassium ions, so that the utilization rate of the flemingia philippinensis is increased, and the problem of resource shortage of the flemingia philippinensis is relieved.
Owner:GUANGDONG PHARMA UNIV

Flavonoid-containing composition

PendingJP2026110166AGlycosideXanthonoid
The inventors have found that quercetin and genistein, individually, suppress the expression of some aging-related genes while promoting the expression of other aging-related genes. Therefore, the main objective was to maintain the repressive effect on some aging-related genes that quercetin, genistein, and their glycosides may have, while suppressing the effect of promoting the expression of other aging-related genes. [Solution] The above problem can be solved by combining two or three components selected from the group consisting of component (i): quercetin and / or its glycosides, component (ii): genistein and / or its glycosides, and component (iii): nobiletin and / or its glycosides.
Owner:SUNSTAR INC

Method for separating and extracting epicatechin, formononin and genistin from caulis spatholobi and application of formononin

The invention discloses a method for separating and extracting epicatechin, formononin and genistin from caulis spatholobi and application of the formononin, belongs to the technical field of natural product extraction and medical application, and relates to an efficient and controllable extraction process. According to the method, the three active ingredients of epicatechin, ononin and genitin can be enriched and purified at the same time from the caulis spatholobi, the potential medicinal value of ononin in gastric cancer treatment is further revealed, and a scientific basis is provided for deep development and comprehensive utilization of the caulis spatholobi.
Owner:YOUJIANG MEDICAL UNIV FOR NATIONALITIES

Compositions and methods for activating physiological health defenses

The present invention provides compositions and methods for activating physiological health defenses. The invention, comprising combinations of, and methods of providing and administering, (1) anthocyanins; (2) β-(1-3,1-6)-D-glucan; (3) chlorogenic acid; (4) curcumin; (5) epigallocatechin-3-gallate (EGCG); (6) genistein; (7) hydroxytyrosol; (8) lycopene (including both cis- and trans-isomers); (9) Lactobacillus reuteri, Akkermansia mucinophila, and / or Ruminoccocus sp. bacteria; (10) omega-3 polyunsaturated fatty acid (PUFA); (11) quercetin; and (12) proanthocyanidins, relieves and alleviates numerous deleterious health conditions and / or to support mammalian physiological health defenses including (but not limited to) angiogenesis, regeneration, microbiome, DNA protection, immunity, metabolism, and adaptive thermogenesis.
Owner:QUINTESSENTIALI LLC

Preparation and application of gamma-cyclodextrin / genistein inclusion compound for relieving oxidative stress

The invention belongs to the field of biological medicine health research, and particularly relates to preparation and application of a gamma-cyclodextrin / genistein inclusion compound for relieving oxidative stress. The inclusion compound is formed by gamma-cyclodextrin and genistein through a self-assembly reaction in a solution. Compared with genistein, the inclusion compound can remarkably relieve oxidative stress injury of PC12 cells caused by organic hydrogen peroxide. Meanwhile, the gamma-cyclodextrin / genistein inclusion compound can remarkably improve the iron reducing capacity of genistein and the DPPH free radical scavenging rate. Therefore, the gamma-cyclodextrin / genistein inclusion compound has a good anti-oxidation effect and an effect of relieving oxidative stress. A new thought is provided for research of natural antioxidants, and a new view angle is provided for treatment of oxidative stress related diseases.
Owner:JILIN UNIVERSITY

Microbial strain for de novo synthesis of gardenin B and application of microbial strain in production of polymethoxylated flavone compound

The invention relates to a recombinant microbial strain for de novo synthesis of gardenin B and application of the recombinant microbial strain in production of polymethoxylated flavone compounds, and belongs to a cross technology of synthetic biology and organic synthetic chemistry. The invention designs and constructs a heterozygous gardenin B biosynthesis pathway, and obtains a microbial strain for synthesizing gardenin B from the beginning. By screening F8H and redox partner types and regulating and controlling subcellular localization, an F8H-redox partner combination with optimal space and type is determined, and an engineering strain of which the gardenin B yield is greatly improved is obtained. The efficient synthesis method of the polymethoxylated flavonoids is established by selecting recombinant microorganisms for synthesizing gardenin B from de novo to perform co-culture fermentation or chemical conversion of fermentation products.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

High-activity fermented astragalus mongholicus and red date compound for improving myocardial function as well as preparation method and application thereof

The invention relates to the technical field of food biology, in particular to a high-activity fermented astragalus mongholicus and red date compound for improving myocardial function, which is prepared by taking Xinjiang Qiang red dates and astragalus mongholicus as main raw materials and matching cellulase, pectinase, beta-glucanase and hydroxypropyl-beta-cyclodextrin. In the preparation process, gradient freezing-microwave pretreatment and ternary composite enzymolysis synergistic wall breaking are adopted, quaternary strains of bifidobacterium longum, bacillus subtilis, saccharomyces cerevisiae and lactobacillus plantarum are compounded, adenosine concentration response type staged solid-state fermentation is performed, and microcapsule embedding stabilizing treatment is performed to obtain the product. The content of cAMP in the product is greater than or equal to 13.0 mu g / g, and the content of calycosin-7-glucoside in astragalus membranaceus is greater than or equal to 1.9 mg / g. The compound can be used for preparing myocardial ischemia pretreatment health-care food and a pharmaceutical composition for adjuvant therapy in the myocardial infarction recovery period, and the dosage forms comprise chewable tablets, oral liquid, capsules and the like.
Owner:ZHONG KE YAO CHUANG (QING DAO) FA JIAO GONG CHENG YOU XIAN GONG SI

Flavonoid-containing composition

PendingJP2026110168AApigeninQuercitrin
The inventors' primary objective was to provide a technology that suppresses inflammation, particularly in aging tissues. [Solution] The above problem can be solved by a composition containing at least one selected from the group consisting of genistein, quercetin, fisetin, nobiletin, kaempferol, apigenin, and naringenin, and glycosides thereof.
Owner:SUNSTAR INC

Co-amorphous solid forms of flavonoids

The present invention relates to new solid forms (NSF) of a flavonoid and a coformer. The NSF are co-amorphous solids of flavonoids and amino acids, as well as the solvates of said co-amorphous solids. The flavonoid is selected from quercetin, genistein, fisetin, apigenin, naringenin, rutin, diosmin, among others. The coformer is selected from lysine and arginine. The NSF have enhanced stability, solubility and pharmacological properties over parent polyphenols. The new solid forms are suitable to be used in pharmaceutical compositions, food products, nutritional supplements and the like.
Owner:ALPARIS S A DE

Genistein having CD38 inhibitory activity, and preparation method and application thereof

The application discloses genistein with CD38 inhibitory activity and a preparation method and application thereof. The preparation method comprises the following steps: crushing dried purslane, adding water and a composite enzyme into the obtained purslane powder to perform enzymolysis; adding ethanol into the obtained enzymolysis liquid to perform ultrasonic-assisted extraction, decompression concentration and organic solvent extraction; performing macroporous adsorption resin separation and elution on the obtained extraction liquid, collecting the eluate; performing gel column chromatography separation and liquid chromatography purification on the obtained eluate, and drying to obtain genistein. The preparation method is simple, the prepared genistein has high purity, and the highest purity can reach 99.05%; and the prepared genistein has good CD38 inhibitory activity, and opens up a new use of purslane genistein. + horizontal promotion of medicines, health products and food.
Owner:OCEAN UNIV OF CHINA

Preparation method of 3'-hydroxygenistein

The present invention provides a method for preparing 3'-hydroxygenistein, comprising the following steps: constructing a genetically recombinant microorganism that expresses tyrosinase; performing a reaction matrix preparation step, wherein the reaction matrix comprises borate, ascorbic acid and genistein; then inoculating the genetically recombinant microorganism in the reaction matrix to perform a bioconversion reaction step to obtain a bioconversion substance; then adding hydrochloric acid solution to the bioconversion substance to perform a termination reaction step to obtain a reaction solution, wherein the reaction solution comprises 3'-hydroxygenistein. Thus, the method for preparing 3'-hydroxygenistein provided by the present invention can prepare high-purity 3'-hydroxygenistein in large quantities.
Owner:BIO JOURDENESS INT GRP CO LTD

High-yield beta-glucosidase strain and application thereof in efficient conversion of genistin

The invention discloses a high-yield beta-glucosidase strain and application of the high-yield beta-glucosidase strain in efficient conversion of genistin, and belongs to the technical field of microbial fermentation and enzyme engineering. In order to solve the problems of low enzyme activity and low conversion efficiency of a beta-glucosidase production strain in the prior art, the invention provides the lactobacillus mucus DQ7-1 of which the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.36230, and the lactobacillus mucus DQ7-1 has the advantages that the lactobacillus mucus DQ7-1 has the preservation number of CGMCC No.36230; the strain is obtained through natural fermentation with soybean whey as a raw material in combination with aesculin color development and p-nitrobenzene-beta-D-glucopyranoside quantitative enzyme activity screening methods, and the beta-glucosaccharase activity of the strain is remarkably higher than that of common lactic acid bacteria. The strain is mainly used for catalyzing efficient conversion of soybean isoflavone glycoside, especially genistin, to genistein in the aglycone form, and has important application value in the fields of functional food, medicine and feed.
Owner:BOHAI UNIV

Application of dragon's blood and active ingredients thereof in preparation of medicine for treating heart failure

The invention provides application of dragon's blood and active ingredients thereof in preparation of a medicine for treating heart failure, and belongs to the technical field of biological medicine. It is found for the first time that the dragon's blood can significantly improve the heart function of a heart failure model animal, reduce the level of a heart failure marker and relieve cardiac hypertrophy, cardiac pulmonary edema, myocarditis infiltration and fibrosis; core active components such as genistein and 3-hydroxycinnamic acid are screened and verified, wherein the genistein can reproduce the overall treatment effect of the dragon's blood. The invention also discloses that the core action mechanism of the composition is to promote macrophage VEGFC secretion, increase heart lymphatic vessel density and promote lymphatic vessel neogenesis, and a brand new natural drug candidate scheme and an intervention strategy are provided for heart failure treatment.
Owner:SHANGHAI UNIV OF T C M

Application of genistein in preparation of anti-colorectal cancer medicine for inhibiting LINC00355 expression

The invention belongs to the technical field of biological medicines, and particularly relates to application of genistein to preparation of an anti-colorectal cancer medicine for inhibiting LINC00355 expression. According to the present invention, the genistein is adopted as the LINC00355 expression inhibitor so as to effectively inhibit the expression of the LINC00355, such that the adsorption effect of the LINC00355 on the miR-150 is relieved, the expression of the miR-150 is up-regulated, the expression of the SGK1 is further inhibited by the miR-150, the activation of the downstream EGFR / PI3K / Akt and MAPK signal channels is finally inhibited, and the activity of the downstream EGFR / PI3K / Akt and MAPK signal channels is inhibited; and inhibition of colorectal cancer cell proliferation, inhibition of colorectal cancer cell cycle G0 / G1 phase, induction of colorectal cancer cell apoptosis and inhibition of colorectal cancer cell migration and invasion ability are realized, so that a better anti-colorectal cancer treatment effect is achieved.
Owner:THE PEOPLES HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION

Method for preparing oligomeric genistein by oxidative conversion of genistein with laccase

PendingCN121931197AAntibacterial agentsNervous disorderCoprinopsis cinereaEnzyme inhibition
The invention discloses a method for preparing oligomeric genistein by oxidative conversion of genistein with laccase. According to the method, the coprinus cinerea laccase Lcc5 is used for preparing the oligomeric genistein, so that the condition for preparing the product is optimized, the conversion rate is increased to about 92%, and the product with higher polymerization degree is obtained. The antioxidant activity, the enzyme inhibition activity, the anti-amyloid aggregation activity and the antibacterial activity of the obtained conversion product are remarkably improved compared with those of monomer genistein. The enzyme has potential application value in oxidative conversion of genistein and other isoflavones to improve the biological value of genistein and other isoflavones.
Owner:ANHUI UNIV

Antibacterial polyurethane medical catheter material and preparation method thereof

The invention discloses an antibacterial polyurethane medical catheter material and a preparation method thereof, and relates to the technical field of polyurethane materials. When the antibacterial polyurethane medical catheter material is prepared, genistein and zinc acetate react to prepare a genistein complex; the preparation method comprises the following steps: sequentially treating boron nitride with sodium hydroxide and kh550 to prepare aminated boron nitride; reacting the aminated boron nitride with a phosphorus-containing flame retardant to prepare functionalized boron nitride; the preparation method comprises the following steps: reacting 2-amino-2-methyl-1, 3-propylene glycol with 4-pyridylaldehyde and 1-bromohexane in sequence to prepare a pyridinium salt monomer; the preparation method comprises the following steps: polymerizing polytetrahydrofuran and diphenylmethane diisocyanate, and carrying out chain extension on a pyridinium monomer to prepare polyurethane; the preparation method comprises the following steps: uniformly mixing polyurethane, a genistein complex and functionalized boron nitride to prepare an antibacterial polyurethane medical catheter material; the antibacterial polyurethane medical catheter material prepared by the preparation method disclosed by the invention has good antibacterial and flame-retardant effects.
Owner:JINING MEDICAL UNIV

Compositions that protect cells from oxidative and mitochondrial stress

PendingUS20260090969A1Organic active ingredientsCosmetic preparationsAcacetinLuteolinidin
There are described compositions comprising an effective amount of a combination of two or more components, said components selected from acacetin, ACTI peptide, alpha-lipolic acid, alprostadil, anisomycin, apigenin, ascorbic acid, astragalus, berberine, β-lapachone, β-hydroxy-beta-methyl-butyrate, Bacopa monnieri, catechin, catechol, chamomile, chrysin, coumestrol, curcumin, dinitrophenol, dinoprost, ellagic acid, (−)-epigallocatechin gallate, green tea extract, fisetin, genistein, ginsenoside RE, glabridin, 18-α-glycyrrhetinic acid, 18-β-glycyrrhetinic acid, glycyrrhizin, hydroquinone, isoquercitrin (EMIQ), kaempferol, kuromanin, leucine, lithium, luteolin, luteolin, luteolinidin, melatonin, menadione, 1-methylnicotinamide (MNA), methyl salicylate, myricetin, nadide, niacin (vitamin B3), nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid adenine dinucleotide (NaAD), nicotinic acid mononucleotide (NaMN), parsley (Petroselinium crispum), phenylephrine, pokeweed mitogen, 15-Δ prostaglandin J2, puromycin, quercetin, quinolinic acid, retinoic acid, trichostatin A, troxrutin, rutin, tryptophan, vitamin D3, withaferin A, wortmannin and zinc (including salts thereof).
Owner:NUCHIDO LTD

Production process and formula for treating body nodules

The invention relates to the technical field of pharmaceutical preparations, and discloses a production process for treating body nodules, which comprises the following steps: S1, extracting and purifying active pharmaceutical ingredients, and preparing liposome quercetin, genistein and sodium hyaluronate; s2, preparing a functional carrier material, namely preparing polyunsaturated phosphatidylcholine and phosphatidylcholine nanoparticles by an emulsification-solvent evaporation method; the invention also discloses a formula for treating body nodules, and the formula comprises the following components in percentage by weight: 15-25% of active pharmaceutical ingredients; 65%-80% of a functional carrier material; 0.2%-1% of an auxiliary reinforcing material; and 5%-10% of a slow release regulator. Precise delivery and controlled release are realized through a multi-responsive nano-carrier, a multi-mode treatment system combining a photothermal effect and magnetic targeting is adopted, the drug targeting and the treatment efficiency are remarkably improved, the drug effect time is prolonged through a slow-release regulator, the drug use frequency is reduced, and the patient compliance is improved.
Owner:苗宝权

Application of genistein to treatment of rifampicin-induced drug-induced liver injury

The invention provides application of genistein to protection of rifampicin-induced drug-induced liver injury. GEN is an extract monomer of a leguminous plant, and intragastric administration is adopted in the invention. According to the technical scheme of the invention, a GEN protection rifampicin induced mouse liver injury model is carried out, and different liver cell lines are used for verifying that GEN of human liver cancer HepG2, human liver cancer Hep3B and normal mouse liver cells AML12 reduces damage of liver cells in vitro. GEN intragastric administration lasts for 16 days, the weight of the liver can be reduced, fatty degeneration can be remarkably improved, deposition of fat including triglyceride and cholesterol in the liver can be reduced, the blood bilirubin level can be reduced, and mice do not die in the whole process; the endogenous mechanism of the gene and GEN increases CH25H expression, the catalytic product 25HC of the latter is increased, and the latter combines and activates LXR alpha and enters the nucleus to promote ABCA transcription, so that cholesterol excretion of liver cells is promoted. The new pharmacological efficacy and liver protection mechanism of GEN are found for the first time, and a foundation is laid for future clinical application.
Owner:CHINA THREE GORGES UNIV

Extraction process of soy isoflavone with high genistein and genistin content and application method of soy isoflavone in sow production

The invention relates to the field of feed additives, and particularly discloses a process for extracting soy isoflavone with high content of genistein and genistin and an application method of the soy isoflavone in sow production. The invention relates to a process for extracting soybean isoflavone with high genistein and genistin content, which comprises the following specific steps: carrying out graded screening on non-transgenic soybeans, carrying out presoaking by using an alcohol mixed solution, carrying out coordinated treatment by using bacteria and enzymes to obtain a molasses sample material, adjusting the sugar degree of the molasses sample material to 50-60 degrees, and crystallizing; separating sugar from the crystallized material, taking out pasty isoflavone, crushing, cleaning and secondarily separating the pasty isoflavone to obtain sugar, ash and pasty isoflavone, and sequentially performing crushing, steam sterilization, vibration screening, hot air drying and secondary screening on the obtained pasty isoflavone to obtain soybean isoflavone; according to the application, the contents of genistein and genistin in the soy isoflavone are increased by combining all the process steps.
Owner:ANYOU BIOTECH GRP

Analysis method for application of wolfberry in preparation of food and medicine for rheumatoid arthritis

This invention discloses an analytical method for the application of wolfberry in the preparation of foods and drugs for rheumatoid arthritis. First, 36 active ingredients and 201 drug targets of wolfberry were obtained through a traditional Chinese medicine systems pharmacology database and analysis platform. Then, 536 targets for rheumatoid arthritis were predicted using Gene Cards and TTD databases, and 55 intersection targets were obtained through Venn diagram analysis. An intersection target network diagram and a "drug-ingredient-target-disease" network diagram were constructed. Topological analysis screened out four core targets: IL1B, JUN, IL6, and TNF, and five core ingredients. Molecular docking results showed that quercetin, genistein, β-sitosterol, stigmasterol, and lycopene strongly bound to the four core targets. This invention provides a theoretical reference for the development of drugs for the treatment of rheumatoid arthritis.
Owner:JING BRAND

Method for increasing content of genistein in flemingia philippinensis by using nitrogen

The invention discloses a method for increasing the content of genistein in flemingia philippinensis by using nitrogen. Culturing the flemingia philippinensis tissue culture seedlings in a propagation culture medium, and subculturing to obtain flemingia philippinensis stem segments with leaves; taking stems of the flemingia philippinensis, and culturing the stems in a rooting culture medium to obtain the flemingia philippinensis with increased genistein content; wherein the propagation culture medium is prepared from MS (Murashige and Skoog), 6-benzyladenine, indoleacetic acid and kinetin; the rooting medium comprises NH4NO3, MS (Murashige and Skoog) and naphthylacetic acid, and the MS does not contain NH4NO3. According to the method for increasing the content of genistein in the flemingia philippinensis by using nitrogen, accumulation of the active ingredient genistein at the root of the flemingia philippinensis is adjusted by adding exogenous nitrogen ions, so that the utilization rate of the flemingia philippinensis is increased, and the problem of resource shortage of the flemingia philippinensis is relieved.
Owner:GUANGDONG PHARMA UNIV

Application of genistein in preparation of medicine for improving brain cognitive impairment caused by low pressure and low oxygen

PendingCN121422011AOrganic active ingredientsNervous disorderDiseaseHypobaric hypoxia
The invention belongs to the technical field of medicines and disease treatment, and particularly relates to application of genistein to preparation of a medicine for improving brain cognitive impairment caused by low pressure and low oxygen. Research results show that low pressure and low oxygen can cause brain cognitive dysfunction of mice. The genistein can relieve brain dysfunction after low-pressure and low-oxygen exposure of mice by inhibiting neuroinflammation, recovering hippocampal neurological functions and improving hippocampal oxidative aggression. The invention provides a novel therapy for brain cognitive impairment caused by low pressure and low oxygen in various leguminous plant components, which is mainly derived from soy isoflavone by verifying a pharmaceutical active component, namely genistein.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY